MedPath
HSA Approval

AA PHARMA HYDROXYZINE CAPSULE 25 mg

SIN04142P

AA PHARMA HYDROXYZINE CAPSULE 25 mg

AA PHARMA HYDROXYZINE CAPSULE 25 mg

April 20, 1990

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE, LIQUID FILLED

ORAL

Medical Information

N05BB01

hydroxyzine

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

CATALENT ONTARIO LIMITED

Active Ingredients

HYDROXYZINE HCl

25 mg

Hydroxyzine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.